Viewing Study NCT00501605


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2025-12-31 @ 7:00 PM
Study NCT ID: NCT00501605
Status: COMPLETED
Last Update Posted: 2011-01-21
First Post: 2007-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module